Intersect ENT Receives $1,018,585 Series C Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=740e2a85-cdfd-41b8-a086-1fc0e1a9bfbe&Preview=1 - Date
9/2/2011 - Company Name
Intersect ENT - Mailing Address
1049 Elwell Court Palo Alto, CA 94303 - Company Description
Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose & Throat surgeons to utilize in providing improved treatment for their patients. - Website
http://www.intersectent.com - Transaction Type
Venture Equity - Transaction Amount
$1,018,585 - Transaction Round
Series C - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing-amended. - M&A Terms
- Venture Investor
Undisclosed
